| Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo PS Shirude, R Shandil, C Sadler, M Naik, V Hosagrahara, S Hameed, ... Journal of Medicinal Chemistry 56 (23), 9701-9708, 2013 | 165 | 2013 |
| Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis R Mishra, S Kohli, N Malhotra, P Bandyopadhyay, M Mehta, MH Munshi, ... Science translational medicine 11 (518), eaaw6635, 2019 | 95 | 2019 |
| In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis S Solapure, N Dinesh, R Shandil, V Ramachandran, S Sharma, ... Antimicrobial agents and chemotherapy 57 (6), 2506-2510, 2013 | 81 | 2013 |
| Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA gyrase B MG Kale, A Raichurkar, SH P, D Waterson, D McKinney, MR Manjunatha, ... Journal of medicinal chemistry 56 (21), 8834-8848, 2013 | 67 | 2013 |
| Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy RR Kale, MG Kale, D Waterson, A Raichurkar, SP Hameed, ... Bioorganic & Medicinal Chemistry Letters 24 (3), 870-879, 2014 | 43 | 2014 |
| Identification and mitigation of a reactive metabolite liability associated with aminoimidazoles A Srivastava, S Ramachandran, SP Hameed, VK Ahuja, VP Hosagrahara Chemical Research in Toxicology 27 (9), 1586-1597, 2014 | 17 | 2014 |
| Effect of repeated dosing on rifampin exposure in BALB/c mice V Hosagrahara, J Reddy, S Ganguly, V Panduga, V Ahuja, M Parab, ... European Journal of Pharmaceutical Sciences 49 (1), 33-38, 2013 | 17 | 2013 |
| PROTACs: current trends in protein degradation by proteolysis-targeting chimeras J Madan, VK Ahuja, K Dua, S Samajdar, M Ramchandra, S Giri BioDrugs 36 (5), 609-623, 2022 | 16 | 2022 |
| A multi-targeting pre-clinical candidate against drug-resistant tuberculosis P Kaur, V Potluri, VK Ahuja, CN Naveenkumar, RV Krishnamurthy, ... Tuberculosis 129, 102104, 2021 | 16 | 2021 |
| Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis. Sci Transl Med 11: eaaw6635 R Mishra, S Kohli, N Malhotra, P Bandyopadhyay, M Mehta, M Munshi, ... | 7 | 2019 |
| Joshanda: A traditional herbal approach for treatment of respiratory catarrh VK Ahuja, M Gulati, S Lakhanpal, M Goswami, S Ahmad Current Respiratory Medicine Reviews 5 (2), 81-89, 2009 | 6 | 2009 |
| Orally bioavailable SMARCA2 degraders with exceptional selectivity and potency C Abbineni, LK Satyam, B Kuila, A Ettam, KA Rawoof, S MR, SV Dukare, ... Cancer Research 81 (13_Supplement), 1144-1144, 2021 | 1 | 2021 |
| Novel, potent and orally bioavailable small molecule CD73 inhibitors for cancer immunotherapy C Venkateshappa, K Narayanan, P Kothandaraman, G Priyadarshani, ... Cancer Research 81 (13_Supplement), 1713-1713, 2021 | 1 | 2021 |
| Development and validation of LC/MS/MS method for Triciribine and its monophosphate metabolite in plasma and RBC: Application to mice pharmacokinetic studies S Narayanan, RK Shandil, VK Ahuja, SS Shanmugam, HM KU, ... Journal of Chromatography B 1174, 122714, 2021 | 1 | 2021 |
| A highly differentiated A2AR inhibitor for potential use in cancer therapy C Venkateshappa, K Narayanan, R Nair, A AB, RVP Putta, J Nagaraj, ... Cancer Research 83 (7_Supplement), 4432-4432, 2023 | | 2023 |
| Discovery of orally bioavailable SMARCA2/4 dual degraders for treatment of acute myeloid leukemia C Abbineni, L Khare, B Kuila, AR Khaji, DB Mahadeo, SV Dukare, ... Cancer Research 82 (12_Supplement), 3729-3729, 2022 | | 2022 |
| Discovery and preclinical evaluation of a novel covalent inhibitor of FABP5 for cancer therapy D Chikkanna, LK Satyam, SK Pnaigrahi, V Khairnar, M Pothuganti, ... Cancer Research 81 (13_Supplement), 1266-1266, 2021 | | 2021 |
| Potent small molecule compounds that selectively inhibit proliferation of ABC-DLBCL cell lines LK Satyam, D Chikkanna, V Khairnar, M Pothuganti, S Panigrahi, ... Cancer Research 77 (13_Supplement), 5108-5108, 2017 | | 2017 |
| Evaluation of anti-inflammatory activity and identification of bioactive compounds from Vitex negundo L., Cardiospermurn halicacabum L. and Tridax procumbens L SM Jachok, C Selvam, A Srivastava, V Ahuja PLANTA MEDICA 73 (9), 802-803, 2007 | | 2007 |
